[(2R)-3-[9-[2-[1-(acetyloxymethyl)cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate;[1-[2-[4-(2,2-dimethoxyethyl)-5,8-dioxo-4,7,13-triazatricyclo[7.3.1.02,7]tridecan-13-yl]-2-oxoacetyl]cyclopentyl]methyl acetate;methane;[(2S)-3-[9-[2-[1-[(2-methoxyacetyl)oxymethyl]cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate;[(2R)-3-[9-[2-[1-[(2-methoxyacetyl)oxymethyl]cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate
C135H193N9O34 — CID 161198452
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2R)-3-[9-[2-[1-(acetyloxymethyl)cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate;[1-[2-[4-(2,2-dimethoxyethyl)-5,8-dioxo-4,7,13-triazatricyclo[7.3.1.02,7]tridecan-13-yl]-2-oxoacetyl]cyclopentyl]methyl acetate;methane;[(2S)-3-[9-[2-[1-[(2-methoxyacetyl)oxymethyl]cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate;[(2R)-3-[9-[2-[1-[(2-methoxyacetyl)oxymethyl]cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate
[(2R)-3-[9-[2-[1-(acetyloxymethyl)cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate;[1-[2-[4-(2,2-dimethoxyethyl)-5,8-dioxo-4,7,13-triazatricyclo[7.3.1.02,7]tridecan-13-yl]-2-oxoacetyl]cyclopentyl]methyl acetate;methane;[(2S)-3-[9-[2-[1-[(2-methoxyacetyl)oxymethyl]cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate;[(2R)-3-[9-[2-[1-[(2-methoxyacetyl)oxymethyl]cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate (PubChem CID 161198452) has the molecular formula C135H193N9O34 and a molecular weight of 2486.06 g/mol. Its IUPAC name is [(2R)-3-[9-[2-[1-(acetyloxymethyl)cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate;[1-[2-[4-(2,2-dimethoxyethyl)-5,8-dioxo-4,7,13-triazatricyclo[7.3.1.02,7]tridecan-13-yl]-2-oxoacetyl]cyclopentyl]methyl acetate;methane;[(2S)-3-[9-[2-[1-[(2-methoxyacetyl)oxymethyl]cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate;[(2R)-3-[9-[2-[1-[(2-methoxyacetyl)oxymethyl]cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate.
Molecular Properties
| Compound Name | [(2R)-3-[9-[2-[1-(acetyloxymethyl)cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate;[1-[2-[4-(2,2-dimethoxyethyl)-5,8-dioxo-4,7,13-triazatricyclo[7.3.1.02,7]tridecan-13-yl]-2-oxoacetyl]cyclopentyl]methyl acetate;methane;[(2S)-3-[9-[2-[1-[(2-methoxyacetyl)oxymethyl]cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate;[(2R)-3-[9-[2-[1-[(2-methoxyacetyl)oxymethyl]cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate |
|---|---|
| PubChem CID | 161198452 |
| Molecular Formula | C135H193N9O34 |
| Molecular Weight | 2486.06 g/mol |
| Exact Mass | 2484.36 |
| IUPAC Name | [(2R)-3-[9-[2-[1-(acetyloxymethyl)cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate;[1-[2-[4-(2,2-dimethoxyethyl)-5,8-dioxo-4,7,13-triazatricyclo[7.3.1.02,7]tridecan-13-yl]-2-oxoacetyl]cyclopentyl]methyl acetate;methane;[(2S)-3-[9-[2-[1-[(2-methoxyacetyl)oxymethyl]cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate;[(2R)-3-[9-[2-[1-[(2-methoxyacetyl)oxymethyl]cyclopentyl]-2-oxoacetyl]-2-oxo-3,9-diazabicyclo[3.3.1]nonan-3-yl]-2-phenylmethoxypropyl] 2-prop-2-enylpent-4-enoate |
| SMILES | C.C.C.C.C=CCC(CC=C)C(=O)OC[C@@H](CN1CC2CCCC(C1=O)N2C(=O)C(=O)C1(COC(=O)COC)CCCC1)OCc1ccccc1.C=CCC(CC=C)C(=O)OC[C@@H](CN1CC2CCCC(C1=O)N2C(=O)C(=O)C1(COC(C)=O)CCCC1)OCc1ccccc1.C=CCC(CC=C)C(=O)OC[C@H](CN1CC2CCCC(C1=O)N2C(=O)C(=O)C1(COC(=O)COC)CCCC1)OCc1ccccc1.COC(CN1CC2C3CCCC(C(=O)N2CC1=O)N3C(=O)C(=O)C1(COC(C)=O)CCCC1)OC |
| InChI | InChI=1S/2C36H48N2O9.C35H46N2O8.C24H35N3O8.4CH4/c2*1-4-12-27(13-5-2)35(43)46-23-29(45-22-26-14-7-6-8-15-26)21-37-20-28-16-11-17-30(33(37)41)38(28)34(42)32(40)36(18-9-10-19-36)25-47-31(39)24-44-3;1-4-12-27(13-5-2)34(42)44-23-29(43-22-26-14-7-6-8-15-26)21-36-20-28-16-11-17-30(32(36)40)37(28)33(41)31(39)35(18-9-10-19-35)24-45-25(3)38;1-15(28)35-14-24(9-4-5-10-24)21(30)23(32)27-16-7-6-8-17(27)22(31)26-12-19(29)25(11-18(16)26)13-20(33-2)34-3;;;;/h2*4-8,14-15,27-30H,1-2,9-13,16-25H2,3H3;4-8,14-15,27-30H,1-2,9-13,16-24H2,3H3;16-18,20H,4-14H2,1-3H3;4*1H4/t3*28?,29-,30?;;;;;/m101...../s1 |
| InChIKey | UUQYHFVJTSVEJQ-QUPQHJKBSA-N |
| XLogP | 14.40 |
| TPSA | 499.78 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 60 |
| Heavy Atoms | 178 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2486.06 |
| LogP ≤ 5 | 14.40 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 34 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161198452 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.